Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Henan Medical University
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1.Male and female subjects with non-small cell lung carcinoma in patients with no available curative treatment options who have limited prognosis(≧3 months)with currently available therapies will be enrolled.
2.The last cytotoxic drug, radiotherapy or surgery≧4 weeks.
3.HB≧90g/L, ANC≧1.5×10e9/L, PLT≧80×10e9/L, TBIL≦1.5×upper limit of nomal, ALT/AST≦2.5×upper limit of nomal, ALT/AST≦5×upper limit of nomal if have liver metastasis, Cr≦1.5×upper limit of nomal or CCr≧60ml/min.
You may not be if
1.Pregnancy or breastfeeding.
2.Known HIV, HBV or HCV infection.
3.Active antoimmune disease.
4.History of severe immediate hypersensitivity to any of the biological products including penicillin.
5.Severe psychiatric disorder which might interfere with the study treatment or examination.
6.Chronic heart failure NYHA≧III.
7.Simultaneous participation in another clinical trial within 4 weeks.
Clareo Health | CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma
